PFE - Pfizer Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5202.05B
Enterprise Value 3247.28B
Trailing P/E 12.72
Forward P/E 111.59
PEG Ratio (5 yr expected) 11.38
Price/Sales (ttm)3.90
Price/Book (mrq)3.10
Enterprise Value/Revenue 34.78
Enterprise Value/EBITDA 611.67

Trading Information

Stock Price History

Beta (5Y Monthly) 0.63
52-Week Change 3-13.31%
S&P500 52-Week Change 321.38%
52 Week High 344.56
52 Week Low 333.97
50-Day Moving Average 338.80
200-Day Moving Average 337.36

Share Statistics

Avg Vol (3 month) 321.02M
Avg Vol (10 day) 319.6M
Shares Outstanding 55.53B
Float 5.53B
% Held by Insiders 10.03%
% Held by Institutions 173.44%
Shares Short (Jan 30, 2020) 461.03M
Short Ratio (Jan 30, 2020) 42.59
Short % of Float (Jan 30, 2020) 41.10%
Short % of Shares Outstanding (Jan 30, 2020) 41.10%
Shares Short (prior month Dec 30, 2019) 457.14M

Dividends & Splits

Forward Annual Dividend Rate 41.52
Forward Annual Dividend Yield 44.12%
Trailing Annual Dividend Rate 31.44
Trailing Annual Dividend Yield 33.90%
5 Year Average Dividend Yield 43.47
Payout Ratio 450.17%
Dividend Date 3Mar 05, 2020
Ex-Dividend Date 4Jan 29, 2020
Last Split Factor 23:1
Last Split Date 3Jun 30, 1999

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 31.44%
Operating Margin (ttm)29.07%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)25.24%

Income Statement

Revenue (ttm)51.75B
Revenue Per Share (ttm)9.29
Quarterly Revenue Growth (yoy)-9.20%
Gross Profit (ttm)41.74B
EBITDA 21.18B
Net Income Avi to Common (ttm)16.27B
Diluted EPS (ttm)2.87
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.15B
Total Cash Per Share (mrq)1.65
Total Debt (mrq)53.98B
Total Debt/Equity (mrq)82.54
Current Ratio (mrq)N/A
Book Value Per Share (mrq)11.77

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A